Skip to main content
OpenTrials

Clinical trial condition

Dwarfism

Explore clinical trials studying Dwarfism. Study availability and eligibility vary by location and protocol.

77 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Dwarfism trial results

Enrolling by Invitation

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia

NCT05929807

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +6 more
Locations
  • Ascendis Pharma Investigational Site Little Rock, Arkansas, United States
  • Ascendis Investigational Site Aurora, Colorado, United States
  • Ascendis Investigational Site Wilmington, Delaware, United States
  • Ascendis Investigational Site Saint Paul, Minnesota, United States
View all 17 locations
View Trial Details
Completed

A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia

NCT04085523

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +6 more
Locations
  • Ascendis Pharma Investigational Site Little Rock, Arkansas, United States
  • Ascendis Pharma Investigational Site Aurora, Colorado, United States
  • Ascendis Pharma Investigational Site Saint Paul, Minnesota, United States
  • Ascendis Pharma Investigational Site Columbia, Missouri, United States
View all 15 locations
View Trial Details
Completed

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

NCT04035811

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Benioff Children's Hospital Oakland Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 32 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

NCT06164951

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • QED Investigative Site San Francisco, California, United States
  • QED Investigative Site Aurora, Colorado, United States
  • QED Investigative Site Baltimore, Maryland, United States
  • QED Investigative Site Columbia, Missouri, United States
View all 27 locations
View Trial Details
Completed

Study of Infigratinib in Children With Achondroplasia

NCT04265651

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View all 19 locations
View Trial Details

Related conditions